An inkjet-printed smartphone-supported electrochemical biosensor system for reagentless point-of-care analyte detection

2021 ◽  
pp. 130447
Author(s):  
Yang Bai ◽  
Qiuquan Guo ◽  
Junfeng Xiao ◽  
Mingyue Zheng ◽  
Dongxing Zhang ◽  
...  
10.2741/s357 ◽  
2013 ◽  
Vol S5 (1) ◽  
pp. 39-71 ◽  
Author(s):  
Arvind Sai Sarathi Vasan

Author(s):  
M. Dutta ◽  
S. Chilukuru ◽  
L. Ramasamy ◽  
Xiaoshan Zhu ◽  
Jaephil Do ◽  
...  

Sensors ◽  
2018 ◽  
Vol 18 (11) ◽  
pp. 4011 ◽  
Author(s):  
Daniel Evans ◽  
Konstantinos Papadimitriou ◽  
Nikolaos Vasilakis ◽  
Panagiotis Pantelidis ◽  
Peter Kelleher ◽  
...  

Point of Care (PoC) diagnostics have been the subject of considerable research over the last few decades driven by the pressure to detect diseases quickly and effectively and reduce healthcare costs. Herein, we demonstrate a novel, fully integrated, microfluidic amperometric enzyme-linked immunosorbent assay (ELISA) prototype using a commercial interferon gamma release assay (IGRA) as a model antibody binding system. Microfluidic assay chemistry was engineered to take place on Au-plated electrodes within an assay cell on a printed circuit board (PCB)-based biosensor system. The assay cell is linked to an electrochemical reporter cell comprising microfluidic architecture, Au working and counter electrodes and a Ag/AgCl reference electrode, all manufactured exclusively via standard commercial PCB fabrication processes. Assay chemistry has been optimised for microfluidic diffusion kinetics to function under continual flow. We characterised the electrode integrity of the developed platforms with reference to biological sampling and buffer composition and subsequently we demonstrated concentration-dependent measurements of H2O2 depletion as resolved by existing FDA-validated ELISA kits. Finally, we validated the assay technology in both buffer and serum and demonstrate limits of detection comparable to high-end commercial systems with the addition of full microfluidic assay architecture capable of returning diagnostic analyses in approximately eight minutes.


Author(s):  
Hadar Ben-Yoav ◽  
Sheryl E. Chocron ◽  
Thomas E. Winkler ◽  
Eunkyoung Kim ◽  
Gregory F. Payne ◽  
...  

2018 ◽  
Vol 110 ◽  
pp. 78-88 ◽  
Author(s):  
Dandan Xu ◽  
Xiwei Huang ◽  
Jinhong Guo ◽  
Xing Ma

Micromachines ◽  
2020 ◽  
Vol 11 (2) ◽  
pp. 220 ◽  
Author(s):  
Niazul I. Khan ◽  
Edward Song

Aptamers are oligonucleotides or peptides that are selected from a pool of random sequences that exhibit high affinity toward a specific biomolecular species of interest. Therefore, they are ideal for use as recognition elements and ligands for binding to the target. In recent years, aptamers have gained a great deal of attention in the field of biosensing as the next-generation target receptors that could potentially replace the functions of antibodies. Consequently, it is increasingly becoming popular to integrate aptamers into a variety of sensing platforms to enhance specificity and selectivity in analyte detection. Simultaneously, as the fields of lab-on-a-chip (LOC) technology, point-of-care (POC) diagnostics, and personal medicine become topics of great interest, integration of such aptamer-based sensors with LOC devices are showing promising results as evidenced by the recent growth of literature in this area. The focus of this review article is to highlight the recent progress in aptamer-based biosensor development with emphasis on the integration between aptamers and the various forms of LOC devices including microfluidic chips and paper-based microfluidics. As aptamers are extremely versatile in terms of their utilization in different detection principles, a broad range of techniques are covered including electrochemical, optical, colorimetric, and gravimetric sensing as well as surface acoustics waves and transistor-based detection.


1991 ◽  
Vol 20 (5) ◽  
pp. 849-852 ◽  
Author(s):  
Yusuke Okawa ◽  
Hiroyuki Kobayashi ◽  
Takashi Ohno

Sign in / Sign up

Export Citation Format

Share Document